Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Subbiah

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Immunologic Research|July 23, 2021
A graph centrality-based approach for candidate gene prediction for type 1 diabetesN B Thummadi, E Vishnu, E V Subbiah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2018
Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trialsS Sen, R Carmagnani Pestana, K Hess, et al.
Haematologica|January 2, 2008
Hypocupremia and bone marrow failureA S Haddad, V Subbiah, A E Lichtin, et al.
Journal of the Indian Dental Association|February 1, 1976
Evaluation of Healex Spray as a post-operative periodontal dressing and its usefulness in cases of Anug, mixed oral infections, apthus ulceration and acute herpetic gingivo-stomatitisA Rajasekhar, C S Prasad, D C Miglani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 5, 2022
Cancer: slaying the nine-headed HydraJ J Adashek, V Subbiah, C B Westphalen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 15, 2009
Of mice and men: divergent risks of teriparatide-induced osteosarcomaV Subbiah, V S Madsen, A K Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 20, 2023
Weight gain in patients with RET aberrant cancers treated with brain penetrant RET selective inhibitorsM A Gouda, M I Hu, M E Cabanillas, et al.
ESMO Open|July 30, 2023
Sodium fluoride (Na<sup>18</sup>F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumorsK Kairemo, M A Gouda, L Buschhorn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitorS Verstovsek, V Subbiah, L Masarova, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignanciesL Weiss, D Zhang, W G Kunz, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Immunologic Research|July 23, 2021
A graph centrality-based approach for candidate gene prediction for type 1 diabetesN B Thummadi, E Vishnu, E V Subbiah, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 12, 2018
Impact of antibiotic use on survival in patients with advanced cancers treated on immune checkpoint inhibitor phase I clinical trialsS Sen, R Carmagnani Pestana, K Hess, et al.
Haematologica|January 2, 2008
Hypocupremia and bone marrow failureA S Haddad, V Subbiah, A E Lichtin, et al.
Journal of the Indian Dental Association|February 1, 1976
Evaluation of Healex Spray as a post-operative periodontal dressing and its usefulness in cases of Anug, mixed oral infections, apthus ulceration and acute herpetic gingivo-stomatitisA Rajasekhar, C S Prasad, D C Miglani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 5, 2022
Cancer: slaying the nine-headed HydraJ J Adashek, V Subbiah, C B Westphalen, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|July 15, 2009
Of mice and men: divergent risks of teriparatide-induced osteosarcomaV Subbiah, V S Madsen, A K Raymond, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 20, 2023
Weight gain in patients with RET aberrant cancers treated with brain penetrant RET selective inhibitorsM A Gouda, M I Hu, M E Cabanillas, et al.
ESMO Open|July 30, 2023
Sodium fluoride (Na<sup>18</sup>F) PET Response Criteria in Solid Tumors (NAFCIST): a framework for response assessment in bone tumorsK Kairemo, M A Gouda, L Buschhorn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 17, 2018
Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitorS Verstovsek, V Subbiah, L Masarova, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Exploring the pathway: clinical utility and open challenges of targeting BRAF alterations in biliary tract cancers and gastrointestinal malignanciesL Weiss, D Zhang, W G Kunz, et al.
Pageof 6